Levonorgestrel + Ethinyl Estradiol

Phase 2Completed

0 watching 0 views this week⚡ Active

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Ovulation

Conditions

Ovulation

Trial Timeline

Dec 1, 2002 → Oct 1, 2004

NCT ID

NCT00254189

About Levonorgestrel + Ethinyl Estradiol

Levonorgestrel + Ethinyl Estradiol is a phase 2 stage product being developed by Pfizer for Ovulation. The current trial status is completed. This product is registered under clinical trial identifier NCT00254189. Target conditions include Ovulation.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00254189	Phase 2	Completed	Dec 1, 2002	Oct 1, 2004	Ovulation

Competing Products

13 competing products in Ovulation

See all competitors

Product	Company	Stage	Hype Score
SHR7280 tablets	Jiangsu Hengrui Medicine	Phase 2	52
SHR7280；Ganirelix Acetate Injection simulant + SHR7280 simulant； Ganirelix Acetate Injection	Jiangsu Hengrui Medicine	Phase 3	77
Follitropin alpha (r-FSH)	Merck	Pre-clinical	23
Recombinant FSH (follitropin alpha)	Merck	Approved	85
MSJ-0011 + urinary hCG (u-hCG) + Follitropin alpha	Merck	Phase 3	77
Lutropin alfa + Follitropin alfa	Merck	Approved	85
AS900672-Enriched 10 microgram (mcg) + AS900672-Enriched 20 mcg + AS900672-Enriched 30 mcg + AS900672-Enriched 40 mcg + Follitropin alfa 75 international unit (IU) + Recombinant human chorionic gonadotropin (r-hCG)	Merck	Phase 2	52
Orlistat Vs Metformin	Roche	Pre-clinical	23
EV/DNG (Qlaira, BAY86-5027, SH T00658K) + EV/DNG (SH T00658L)	Bayer	Phase 2	49
Myo-inositol + Clomiphene Citrate	Richter Gedeon	Approved	82
corifollitropin alfa + recombinant Follicle Stimulating Hormone (recFSH) + human Chorion Gonadotropin (hCG) + hCG Bolus injection	Organon	Phase 2	47
usual administration of exogenous recombinant FSH	Organon	Pre-clinical	18
Follitropin beta	Organon	Pre-clinical	18

Other Products from Pfizer